SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.890
+0.100 (5.59%)
Feb 13, 2026, 4:08 PM HKT
SinoMab BioScience Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -144.34 | -185.14 | -243.11 | -284.16 | -288.19 | -122.6 |
Depreciation & Amortization | 29.03 | 29.03 | 34.77 | 27.03 | 20.32 | 10.67 |
Other Amortization | 1.25 | 1.25 | 1.29 | 1 | 0.34 | - |
Loss (Gain) From Sale of Assets | - | - | -1.24 | 1.44 | - | - |
Asset Writedown & Restructuring Costs | - | - | - | 1.48 | - | - |
Loss (Gain) From Sale of Investments | -0.5 | -0.5 | 0.51 | -39.43 | -1.34 | -28.25 |
Loss (Gain) on Equity Investments | - | - | - | 5.4 | 4.29 | 0.75 |
Stock-Based Compensation | 6.82 | 6.82 | 19 | 5.02 | 62.9 | 34.9 |
Other Operating Activities | 21.26 | 18.38 | 6.58 | 4.96 | 7.99 | 2.42 |
Change in Accounts Payable | 1.71 | 1.71 | -12.31 | -10.84 | 34 | -21.08 |
Change in Other Net Operating Assets | -2.35 | -2.35 | 60.66 | -12.44 | 12.64 | -18.14 |
Operating Cash Flow | -87.12 | -130.8 | -133.85 | -300.54 | -147.06 | -141.34 |
Capital Expenditures | -26.06 | -41.17 | -103.34 | -112.75 | -198.23 | -75.96 |
Sale of Property, Plant & Equipment | 0.49 | 0.04 | 0.01 | - | - | - |
Sale (Purchase) of Intangibles | -0.37 | -0.33 | -0.55 | -1.63 | -16.69 | -16.37 |
Investment in Securities | -0.4 | -13.03 | 0.11 | 33.93 | 75.87 | -86.9 |
Other Investing Activities | 43.47 | -39.99 | 6.86 | -0.9 | 1.34 | - |
Investing Cash Flow | 17.14 | -94.48 | -96.92 | -81.36 | -137.7 | -179.22 |
Long-Term Debt Issued | - | 97.37 | 124.19 | 71.76 | 143.32 | 40.18 |
Total Debt Issued | 34.96 | 97.37 | 124.19 | 71.76 | 143.32 | 40.18 |
Long-Term Debt Repaid | - | -73.25 | -43.73 | -10.57 | -21.44 | -6.29 |
Total Debt Repaid | -117.86 | -73.25 | -43.73 | -10.57 | -21.44 | -6.29 |
Net Debt Issued (Repaid) | -82.91 | 24.12 | 80.46 | 61.19 | 121.88 | 33.89 |
Issuance of Common Stock | 106.52 | 54.85 | 10.04 | 46.09 | - | - |
Repurchase of Common Stock | - | - | - | - | -59.67 | - |
Other Financing Activities | -5.53 | -5.7 | -8.23 | -4.99 | -4.69 | -52.7 |
Financing Cash Flow | 18.09 | 73.27 | 82.27 | 102.29 | 57.52 | -18.81 |
Foreign Exchange Rate Adjustments | -0.69 | 10.25 | 9.28 | 59.52 | -20.14 | -51.13 |
Net Cash Flow | -52.58 | -141.76 | -139.22 | -220.1 | -247.39 | -390.5 |
Free Cash Flow | -113.18 | -171.97 | -237.19 | -413.29 | -345.3 | -217.29 |
Free Cash Flow Margin | -1976.25% | -8487.96% | -17376.19% | -10250.22% | -1295.33% | -1702.92% |
Free Cash Flow Per Share | -0.10 | -0.16 | -0.23 | -0.42 | -0.35 | -0.22 |
Cash Interest Paid | 5.53 | 5.7 | 8.23 | 4.99 | 4.69 | 3.45 |
Levered Free Cash Flow | -35.8 | -176.4 | -246.47 | -209.19 | -272.87 | -214.34 |
Unlevered Free Cash Flow | -30.57 | -170.98 | -242.35 | -206.09 | -269.23 | -212.83 |
Change in Working Capital | -0.64 | -0.64 | 48.34 | -23.27 | 46.64 | -39.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.